TABLE 7

T0 adiponectin concentration (μg/ml) according to adiponectin gene polymorphisms

Genotypes
P*
GGGAAA
G-11391A
 Men21.4 ± 9.7 (239)23.7 ± 8.3 (57)31.9 (1)0.020
 Women31.4 ± 12.1 (121)41.3 ± 13.0 (35)<0.001
C-11377GCCCGGG
 Men22.5 ± 9.3 (180)20.5 ± 9.2 (97)23.7 ± 11.0 (21)0.112
 Women32.2 ± 13.0 (81)35.8 ± 12.5 (67)30.1 ± 13.9 (9)0.102
T45GTTTGGG
 Men21.5 ± 9.4 (219)23.5 ± 9.7 (73)19.1 ± 7.4 (7)0.208
 Women32.8 ± 11.8 (121)35.4 ± 15.9 (33)44.4 ± 16.2 (4)0.300
G276TGGGTTT
 Men22.2 ± 10.2 (149)21.7 ± 8.7 (125)21.7 ± 8.7 (21)0.997
 Women33.8 ± 12.8 (93)33.8 ± 13.2 (53)31.3 ± 13.5 (11)0.712
  • Data are means ± SD (n). The adiponectin levels were only measured in future hyperglycemic (IFG/type 2 diabetes) and sex-, age-, BMI-matched normoglycemic control subjects.

  • *

    * GG versus A+.